Sobi and Innate announce partnership is now effective following completion of closing conditions

Contributed by: PR Newswire

Tags

SOBI-Innate-Partners

More Like This

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Sobi share new clinical data across multiple hematologic diseases at EHA 2025

Sobi publishes Q3 2023 report: Strong revenue and solid performance

Sobi showcases new data across rare inflammatory conditions at ACR 2025

Sobi will showcase extensive research and clinical outcomes at ISTH 2025

Sobi Q3 2024 report: Strong growth and significant pipeline momentum

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

PR Newswire associated0

Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.